Al Shihabi A, Tebon PJ, Nguyen HTL et al (2024) The landscape of drug sensitivity and resistance in sarcoma. Cell Stem Cell 31(10):1524-1542.e1524. https://doi.org/10.1016/j.stem.2024.08.010

Article  CAS  PubMed  Google Scholar 

Gamboa AC, Gronchi A, Cardona K (2020) Soft-tissue sarcoma in adults: an update on the current state of histiotype-specific management in an era of personalized medicine. CA Cancer J Clin 70(3):200–229. https://doi.org/10.3322/caac.21605

Article  PubMed  Google Scholar 

Ryan CW, Merimsky O, Agulnik M et al (2016) PICASSO III: a phase III, placebo-controlled study of doxorubicin with or without palifosfamide in patients with metastatic soft tissue sarcoma. J Clin Oncol 34(32):3898–3905. https://doi.org/10.1200/jco.2016.67.6684

Article  CAS  PubMed  Google Scholar 

Kirthiga Devi SS, Singh S, Joga R et al (2024) Enhancing cancer immunotherapy: exploring strategies to target the PD-1/PD-L1 axis and analyzing the associated patent, regulatory, and clinical trial landscape. Eur J Pharm Biopharm 200:114323. https://doi.org/10.1016/j.ejpb.2024.114323

Article  CAS  PubMed  Google Scholar 

Liu B, Zhou H, Tan L et al (2024) Exploring treatment options in cancer: tumor treatment strategies. Signal Transduct Target Ther 9(1):175. https://doi.org/10.1038/s41392-024-01856-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grünewald TG, Alonso M, Avnet S et al (2020) Sarcoma treatment in the era of molecular medicine. EMBO Mol Med 12(11):e11131. https://doi.org/10.15252/emmm.201911131

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ho D, Quake SR, McCabe ERB et al (2020) Enabling technologies for personalized and precision medicine. Trends Biotechnol 38(5):497–518. https://doi.org/10.1016/j.tibtech.2019.12.021

Article  CAS  PubMed  PubMed Central  Google Scholar 

Atlı Şekeroğlu Z, Şekeroğlu V (2024) A review on patient-derived 3D micro cancer approach for drug screen in personalized cancer medicine. Curr Cancer Drug Targets. https://doi.org/10.2174/0115680096285910240206044830

Article  Google Scholar 

Trivedi S, Tilsed C, Liousia M et al (2024) Transcriptomic analysis-guided assessment of precision-cut tumor slices (PCTS) as an ex-vivo tool in cancer research. Sci Rep 14(1):11006. https://doi.org/10.1038/s41598-024-61684-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sharma K, Dey S, Karmakar R et al (2024) A comprehensive review of 3D cancer models for drug screening and translational research. Cancer Innov 3(1):e102. https://doi.org/10.1002/cai2.102

Article  CAS  PubMed  Google Scholar 

Ireson CR, Alavijeh MS, Palmer AM et al (2019) The role of mouse tumour models in the discovery and development of anticancer drugs. Br J Cancer 121(2):101–108. https://doi.org/10.1038/s41416-019-0495-5

Article  PubMed  PubMed Central  Google Scholar 

Liu Y, Wu W, Cai C et al (2023) Patient-derived xenograft models in cancer therapy: technologies and applications. Signal Transduct Target Ther 8(1):160. https://doi.org/10.1038/s41392-023-01419-2

Article  PubMed  PubMed Central  Google Scholar 

Higuchi T, Igarashi K, Yamamoto N et al (2021) Osteosarcoma patient-derived orthotopic xenograft (PDOX) models used to identify novel and effective therapeutics: a review. Anticancer Res 41(12):5865–5871. https://doi.org/10.21873/anticanres.15406

Article  CAS  PubMed  Google Scholar 

Higuchi T, Igarashi K, Yamamoto N et al (2022) Review: Precise sarcoma patient-derived orthotopic xenograft (PDOX) mouse models enable identification of novel effective combination therapies with the cyclin-dependent kinase inhibitor palbociclib: a strategy for clinical application. Front Oncol 12:957844. https://doi.org/10.3389/fonc.2022.957844

Article  CAS  PubMed  PubMed Central  Google Scholar 

Higuchi T, Yamamoto N, Hayashi K et al (2023) High clinical concordance of drug resistance in patient-derived orthotopic xenograft (PDOX) mouse models: first step to validated precise individualized cancer chemotherapy. Anticancer Res 43(10):4277–4284. https://doi.org/10.21873/anticanres.16622

Article  CAS  PubMed  Google Scholar 

Hoffman RM (2017) Patient-derived orthotopic xenograft (PDOX) models of melanoma. Int J Mol Sci. https://doi.org/10.3390/ijms18091875

Article  PubMed  PubMed Central  Google Scholar 

Igarashi K, Kawaguchi K, Murakami T et al (2020) Patient-derived orthotopic xenograft models of sarcoma. Cancer Lett 469:332–339. https://doi.org/10.1016/j.canlet.2019.10.028

Article  CAS  PubMed  Google Scholar 

Furukawa T, Fu X, Kubota T et al (1993) Nude mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically intact tissue. Cancer Res 53(5):1204–1208

CAS  PubMed  Google Scholar 

Furukawa T, Kubota T, Watanabe M et al (1993) Orthotopic transplantation of histologically intact clinical specimens of stomach cancer to nude mice: correlation of metastatic sites in mouse and individual patient donors. Int J Cancer 53(4):608–612. https://doi.org/10.1002/ijc.2910530414

Article  CAS  PubMed  Google Scholar 

Hiroshima Y, Maawy A, Zhang Y et al (2014) Metastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19–9-conjugated fluorophore. PLoS ONE 9(12):e114310. https://doi.org/10.1371/journal.pone.0114310

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hiroshima Y, Maawy A, Zhang Y et al (2016) Patient-derived mouse models of cancer need to be orthotopic in order to evaluate targeted anti-metastatic therapy. Oncotarget 7(44):71696–71702. https://doi.org/10.18632/oncotarget.12322

Article  PubMed  PubMed Central  Google Scholar 

Hiroshima Y, Zhang Y, Zhang N et al (2015) Establishment of a patient-derived orthotopic Xenograft (PDOX) model of HER-2-positive cervical cancer expressing the clinical metastatic pattern. PLoS ONE 10(2):e0117417. https://doi.org/10.1371/journal.pone.0117417

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoffman RM (2015) Patient-derived orthotopic xenografts: better mimic of metastasis than subcutaneous xenografts. Nat Rev Cancer 15(8):451–452. https://doi.org/10.1038/nrc3972

Article  CAS  PubMed  Google Scholar 

Togo S, Wang X, Shimada H et al (1995) Cancer seed and soil can be highly selective: human-patient colon tumor lung metastasis grows in nude mouse lung but not colon or subcutis. Anticancer Res 15(3):795–798

CAS  PubMed  Google Scholar 

Nomura T, Kurebayashi J, Moriya T et al (2021) A case of rare matrix-producing triple-negative breast carcinoma for which drug response in a patient-derived orthotopic xenograft mouse model was correlated with patient response. Anticancer Res 41(12):6191–6197. https://doi.org/10.21873/anticanres.15438

Article  CAS  PubMed  Google Scholar 

Turner MA, Hollandsworth HM, Amirfakhri S et al (2022) Anti-mucin 4 fluorescent antibody brightly targets colon cancer in patient-derived orthotopic xenograft mouse models: a proof-of-concept study for future clinical applications. Am J Surg 224(4):1081–1085. https://doi.org/10.1016/j.amjsurg.2022.05.036

Article  PubMed  PubMed Central  Google Scholar 

Sugisawa N, Higuchi T, Han Q et al (2021) Oral recombinant methioninase combined with paclitaxel arrests recalcitrant ovarian clear cell carcinoma growth in a patient-derived orthotopic xenograft (PDOX) nude-mouse model. Cancer Chemother Pharmacol 88(1):61–67. https://doi.org/10.1007/s00280-021-04261-x

Article  CAS  PubMed  Google Scholar 

Sugisawa N, Miyake K, Higuchi T et al (2022) High Incidence of lymph-node metastasis in a pancreatic-cancer patient-derived orthotopic xenograft (PDOX) NOG-mouse model. Anti